Jan 10, 2024 / 11:00PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Welcome, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Ionis. I'm joined on stage by the company's CEO, Brett Monia. We're going to have a Q&A session after he gives a presentation on the business. (Operator Instructions) So with that, let me pass it over to Brett.
Brett P. Monia - Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
Thank you, Jess. Thank you, JPMorgan, for the opportunity to speak today on the great progress we're making at Ionis on behalf of the company. Ionis, today -- I'm very excited, very pleased to be presenting on the progress we're making at Ionis as this really great company enters into a new era, an era that's poised to transform human therapeutics to unlock better futures for patients and also to drive next-level value for all stakeholders. During my presentation, I will be making forward-looking statements.
So at Ionis, we have been and
Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers